Informace o publikaci

Immunology follow-up after rituximab treatment in pediatric non Hodgkin lymfoma patients

Autoři

HLAVÁČKOVÁ Eva KŘENOVÁ Zdenka ŠTĚRBA Jaroslav LITZMAN Jiří

Druh Konferenční abstrakty
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Popis Rituximab treatment leads to absolute transitional CD19+ B lymphocytopenia. IgG decrease could be delayed after the B cell recovery in the periphery. Clinical and laboratory sights of antibody secondary deficiency should be regularly monitored.
Související projekty: